Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2021-A00423-38 | Other Identifier | IDRCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Euromov Digital Health in Motion Montpellier France | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Intro:
Huntington's disease is a neurodegenerative disease that affects the brain, inducing a dysfunction and death of the middle spiny striatal projection neurons and a progressive alteration of cognitive and motor functions, and psycho-behavioral problems. There is currently no curative treatment but we know hat a multidisciplinary care can optimize the functioning and the quality of life of the patients with Huntington's disease.
A meta-analysis of 18studies indicates that exercise and physical activity can improve motor function, gait speed and balance, and would also improve self-confidence, independence, well-being, reduced apathy and better socialization with family and friends.
Hypothesis/Objective The hypothesis is that the inclusion of a 4 week-program with Adapted Physical Activity (APA) during a rehabilitation stay will improve some motor, cognitive and psycho-behavioral abilities, compared to the control group.
Method
The patients will be randomized into two groups :
The control group will have the "classic" program performed in the standard of care with: kinesitherapy, soft gym, medico-social workshop, cognitive workshop, creative workshop, individual care (rehabilitation, rest, and creation).
The experimental APA group will have in addition of the classic program, 6 APA workshops per week with collective support : Adapted Physical workshops, adapted cycling, therapeutic (horseback/equestrian) riding, cultural or leisure outings, situation tests
For the two groups, at the start of the 4 weeks of rehabilitation program an initial visit will be performed with, as part of this research, a clinical examination, a neurological examination, a dietary consultation, as well as a biological assessment as part of habitual care.
The clinical examination, the neurological examination and the dietary consultation will be performed each week, during the 4 weeks of the program,
At the end of the study, one month after the rehabilitation of the patient, a visit by phone-call will be performed for the patient and his caregiver.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Adapted Physical workshops | Experimental | The experimental APA group will have in addition of the classic program, 6 APA workshops per week with collective care : Adapted Physical workshops, adapted cycling, therapeutic (horseback/equestrian) riding, cultural or leisure outings, situation tests |
|
| Control | Other | Standard of care The control group will have the "classic" program performed in the standard of care with : kinesitherapy, soft gym, medico-social workshop, cognitive workshop, creative workshop, individual care (rehabilitation, rest, creation). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Adapted Physical Activity program | Behavioral | classic 4-week rehabilitation program (standard care) + 6 APA workshops per week with collective care |
|
| Measure | Description | Time Frame |
|---|---|---|
| Motor function score of Unified Huntington's Disease Rating Scale (UHDRS) | UHDRS:Unified Huntington's Disease Rating Scale , minimum value: 0 maximum value: 124 higher score means a worse outcome Success will be defined by an improvement of the motor function score | Change from Baseline at 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| cognitive function score of Unified Huntington's Disease Rating Scale (UHDRS) using Stroop test | UHDRS:Unified Huntington's Disease Rating Scale , minimal number of correct answers:0 maximal number of correct answers:100 higher score means a better outcome Success will be defined by an improvement of the cognitive function score | Change from Baseline at 1 month |
Not provided
Inclusion Criteria for the Patient :
Inclusion Criteria for the Caregiver :
Exclusion Criteria:
Exclusion criteria for the Caregiver :
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pierre-André Natella, PhD | Assistance Publique - Hôpitaux Paris | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital Marin de Hendaye | Hendaye | 64700 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 41773646 | Derived | Brusseau M, Soudrie B, Bachoud-Levi AC, Bannier S, Bourdain F, Jenkins M, Natella PA, Bombenger N, Boiche J. A moderate-intensity exercise program during inpatient rehabilitation for middle stage Huntington's disease: A randomized controlled trial. J Huntingtons Dis. 2026 Mar 3:18796397261422975. doi: 10.1177/18796397261422975. Online ahead of print. |
Not provided
Not provided
APHP IS DATA'S OWNER, PLEASE CONTACT BOARD
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006816 | Huntington Disease |
| ID | Term |
|---|---|
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
controlled randomized trial with two parallel arms
Not provided
Not provided
Not provided
Not provided
| Control | Other | classic 4-week rehabilitation program (standard care) |
|
| psycho-behavioral function score of Unified Huntington's Disease Rating Scale (UHDRS) | UHDRS:Unified Huntington's Disease Rating Scale , minimum value:0 maximal value:88 higher score means a worse outcome Success will be defined by an improvement of the behavioral function score | Change from Baseline at 1 month |
| D003704 | Dementia |
| D002819 | Chorea |
| D020820 | Dyskinesias |
| D009069 | Movement Disorders |
| D020271 | Heredodegenerative Disorders, Nervous System |
| D019636 | Neurodegenerative Diseases |
| D030342 | Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D003072 | Cognition Disorders |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |